Jefferies & Co. expects an inline quarter from HEALTHSOUTH Corp. HLS.
In a note to clients, Jefferies writes, "HLS has already provided its initial 4Q observations, with mgmt anticipating discharge
growth of 5.3% Y/Y (SS +2.9%) and a 2.5%-2.7% Y/Y increase in rev/discharge. We expect the company to remain conservative with its initial FY11 EBITDA guidance and would not be surprised to see EPS guidance provided on a fully taxed basis -- cash taxes would not be impacted. Given the lack of potential catalysts in HLS' Q4 print, we expect the stock to trade sideways on the quarter."
Shares of HLS gained $1.00 on Friday to close at $23.59, a gain of 4.4%.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in